What are you looking for today?

Borrello, Maria Teresa, Ruzic, Dusan, Paish, Hannah, Graham, Eleanor, L. Collins, Amy, Scott, Rebecca, Higginbotham, Sam, Radovic, Branko, Nelson, Glyn, Bulmer, David, Borthwick, Lee A., Robinson, Stuart M., French, Jeremy, Moir, John, White, Steve A., Wilson, Colin, Pandanaboyana, Sanjay, Hammond, John, Thakkar, Rohan, Alrawashdeh, Wasfi, Figueiredo, Rodrigo, Petkovic, Milos, Nikolic, Katarina, Oakley, Fiona, Mann, Derek A. and Mann, Jelena (2025) Pharmacological manipulation of liver fibrosis progressionusing novel HDAC6 inhibitors. FEBS Journal. ISSN 1742-464X

Document

  • [thumbnail of The FEBS Journal - 2025 - Borrello - Pharmacological manipulation of liver fibrosis progression using novel HDAC6.pdf]
    The FEBS Journal - 2025 - Borrello - Pharmacological manipulation of liver fibrosis progression using novel HDAC6.pdf
    Available under License Creative Commons Attribution.

Abstract

Abstract

Chronic liver injury characterized by unresolved hepatitis leads to fibrosis,potentially progressing to cirrhosis and hepatocellular carcinoma. Effectivetreatments for halting or reversing liver fibrosis are currently lacking. Thisstudy investigates the potential of HDAC6 as a therapeutic target in liverfibrosis. We synthesized two selective HDAC6 inhibitors, DR-3 andFDR2, and assessed their effects on hepatic stellate cell (HSC) activationand liver fibrosis using human precision cut liver slices (hPCLS). Moleculardocking, deacetylation inhibition assays, and various cellular assays wereemployed to evaluate the specificity and anti-fibrotic efficacy of these inhib-itors. DR-3 and FDR2 demonstrated high selectivity for HDAC6 overHDAC1, significantly inhibiting HSC activation markers and fibrogenicgene expression. Both inhibitors increased acetylation of a-tubulin and sup-pressed TGF-b1-induced SMAD signaling in HSCs. In human precisioncut liver slices (hPCLS), DR-3 and FDR2 reduced fibrogenic protein levelsand collagen deposition. The selective inhibition of HDAC6 by DR-3 andFDR2 effectively reduces HSC activation and fibrogenesis in liver models,supporting further investigation of HDAC6 inhibitors as potential anti-fibrotic therapies

Item Type: Article
Uncontrolled Keywords: HDAC6 inhibitors, histone deacetylase inhibitors, human precision cut liver slices, liver fibrosis, therapy.
Depositing User: Teresa Borrello
URI: https://sure.sunderland.ac.uk/id/eprint/18888

Further Details

More Information

Uncontrolled Keywords
HDAC6 inhibitors, histone deacetylase inhibitors, human precision cut liver slices, liver fibrosis, therapy.
Depositing User

Identifiers

Item ID
18888
Identification Number
ISSN
1742-464X

Users with ORCIDS

ORCID for Maria Teresa Borrello

Catalogue record

Date Deposited
19 Mar 2025 12:24
Last Modified
21 Nov 2025 11:22

Contributors

Author
Dusan Ruzic
Author
Hannah Paish
Author
Eleanor Graham
Author
Amy L. Collins
Author
Rebecca Scott
Author
Sam Higginbotham
Author
Branko Radovic
Author
Glyn Nelson
Author
David Bulmer
Author
Lee A. Borthwick
Author
Stuart M. Robinson
Author
Jeremy French
Author
John Moir
Author
Steve A. White
Author
Colin Wilson
Author
Sanjay Pandanaboyana
Author
John Hammond
Author
Rohan Thakkar
Author
Wasfi Alrawashdeh
Author
Rodrigo Figueiredo
Author
Milos Petkovic
Author
Katarina Nikolic
Author
Fiona Oakley
Author
Derek A. Mann
Author
Jelena Mann

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year